Abstract
The tumor microenvironment (TME) in pediatric cancers is profoundly shaped by the unique biological context of childhood development. Unlike adult tumors, pediatric malignancies arise in growing tissues, where evolving immune systems, dynamic stromal elements, and distinct hormonal and microbial influences converge to create highly specialized tumor-supportive niches. This review explores how developmental processes interact with tumor biology to drive immune evasion, therapy resistance, and disease progression. Key mechanisms such as extracellular matrix remodeling, metabolic reprogramming, and epigenetic plasticity are highlighted as critical contributors to treatment failure. Also, the recent advancements in nanomedicine, circulating markers makes it possible for interventions to be more precise and age-informed. The integration of developmental biology along with tumor ecosystem can emphasis the necessity of developing treatment plans that take into account risks and advantages associated with pediatric TME.